CVE-2018-8868 in MyCareLink Patient Monitor
Summary
by MITRE
Medtronic MyCareLink Patient Monitor, 24950 MyCareLink Monitor, all versions, and 24952 MyCareLink Monitor, all versions, contains debug code meant to test the functionality of the monitor's communication interfaces, including the interface between the monitor and implantable cardiac device. An attacker with physical access to the device can apply the other vulnerabilities within this advisory to access this debug functionality. This debug functionality provides the ability to read and write arbitrary memory values to implantable cardiac devices via inductive or short range wireless protocols. An attacker with close physical proximity to a target implantable cardiac device can use this debug functionality.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Analysis
by VulDB Data Team • 05/22/2025
The vulnerability identified as CVE-2018-8868 affects Medtronic's MyCareLink Patient Monitor devices, specifically the 24950 and 24952 models across all software versions. This represents a critical security flaw that stems from the inclusion of debug code within production firmware, a practice that violates fundamental security principles and creates persistent attack vectors. The debug functionality was originally intended for development and testing purposes but was inadvertently left enabled in deployed devices, creating a backdoor that can be exploited by malicious actors with physical access to the monitoring equipment. The vulnerability specifically targets the communication interfaces between the patient monitor and implantable cardiac devices, which are typically secured through inductive or short-range wireless protocols designed to prevent unauthorized access to critical medical device operations.
The technical implementation of this vulnerability involves the presence of hardcoded debug commands within the device firmware that allow for arbitrary memory access to connected implantable cardiac devices. When an attacker gains physical proximity to the MyCareLink monitor and exploits other vulnerabilities within the same advisory set, they can activate this debug functionality to perform read and write operations on memory locations within the implantable device. This capability directly maps to CWE-254, which addresses weaknesses in security features that allow unauthorized access to system resources, and represents a severe form of privilege escalation that bypasses normal security controls. The attack vector requires close physical proximity to the target device, aligning with ATT&CK technique T1547.001 for Windows systems and similar physical attack patterns in medical device environments, but the implications are far more severe due to the direct control over life-supporting medical equipment.
The operational impact of this vulnerability extends beyond traditional cybersecurity concerns into critical patient safety and medical device integrity domains. An attacker with access to the debug functionality can potentially modify device parameters, alter pacing settings, or disable critical safety features of implantable cardiac devices, creating immediate and potentially fatal risks for patients. The vulnerability undermines the fundamental security model of medical devices, where physical access controls are typically considered sufficient protection against remote attacks. This represents a significant gap in the defense-in-depth strategy for medical device security, as the debug code essentially provides an unauthorized administrative interface to critical life-support equipment. The implications align with NIST SP 800-82 guidelines for industrial control systems security, which emphasize that medical devices require robust security measures to prevent unauthorized access to critical functions, particularly when they interface with human physiology.
Mitigation strategies for this vulnerability require immediate physical security measures combined with firmware updates where available. Organizations should implement strict access controls around medical device monitoring equipment, ensuring that only authorized personnel can physically approach these devices. The first step involves identifying all affected devices within the network and implementing network segmentation to prevent lateral movement if physical access is compromised. Device manufacturers should provide firmware patches that disable debug functionality and implement proper authentication mechanisms for any legitimate diagnostic access. Additionally, healthcare organizations should establish protocols for device access logging and regular security assessments of medical equipment, following guidelines from the FDA's guidance on medical device cybersecurity and the IEC 62443 standards for industrial automation and control systems security. The vulnerability serves as a stark reminder that medical device security must account for both traditional network-based attacks and physical security considerations, particularly when devices interface with critical human health systems.